Pulsatile administration of the EGF receptor inhibitor Iressa (ZD1839) is significantly more effective than continuous dosing for sensitizing tumors to taxol Meeting Abstract


Authors: Solit, D. B.; She, Y.; Moasser, M. M.; Hudis, C. A.; Kris, M. G.; Scher, H. I.; Rosen, N.; Sirotnak, F. M.
Abstract Title: Pulsatile administration of the EGF receptor inhibitor Iressa (ZD1839) is significantly more effective than continuous dosing for sensitizing tumors to taxol
Meeting Title: 94th Annual Meeting of the American Association for Cancer Research (AACR)
Keywords: cell apoptosis; tumor sensitization
Journal Title: Proceedings of the American Association for Cancer Research Annual Meeting
Volume: 44
Meeting Dates: 2003 Jul 11-14
Meeting Location: Washington, DC
ISSN: 0197-016X
Publisher: American Association for Cancer Research  
Date Published: 2003-07-01
Start Page: 1318
End Page: 1318
Language: English
ACCESSION: BCI:BCI200300499087
PROVIDER: biosis
Notes: Meeting abstract: LB-5 -- 94th Annual Meeting of the American Association for Cancer Research -- Washington, DC, USA -- July 11-14, 2003 -- Source: Biosis
MSK Authors
  1. Mark M Moasser
    56 Moasser
  2. Clifford Hudis
    905 Hudis
  3. Neal Rosen
    425 Rosen
  4. David Solit
    779 Solit
  5. Yuhong She
    31 She
  6. Howard Scher
    1130 Scher
  7. Mark Kris
    869 Kris
  8. Francis M Sirotnak
    184 Sirotnak